Botanical species · safety record
Caesalpinia bonduc
The EFSA Compendium of Botanicals holds 6 constituent measurements and 2 adverse-effect records for Caesalpinia bonduc. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Caesalpinia bonduc (L.) Roxb.
Regulatory presence
No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.
What the records describe
Constituents measured
- Alkaloids1
- Bonducellpin c1
- Cardiac glycosides1
- Coumarins1
- Furan derivatives1
- Tannins1
Plant parts
- Leaves4
- Roots and other underground parts4
Preparations
- Solvent extraction8
Effect types
- Endocrine2
Target tissues
- Uterus2
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Alkaloids | Leaves | Solvent extraction | — | Phytochemical screening | Resolve DOI |
| Bonducellpin c | Roots and other underground parts | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Cardiac glycosides | Leaves | Solvent extraction | — | Phytochemical screening | Resolve DOI |
| Coumarins | Leaves | Solvent extraction | — | Phytochemical screening | Resolve DOI |
| Furan derivatives | Roots and other underground parts | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Tannins | Leaves | Solvent extraction | — | Phytochemical screening | Resolve DOI |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Endocrine | Uterus | Roots and other underground parts | Solvent extraction | Rat (as animal) | Reproduction toxicity | No resolvable identifier |
| Endocrine | Uterus | Roots and other underground parts | Solvent extraction | Rat (as animal) | Reproduction toxicity | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Peter, SR., Tinto, WF., McLean, S., Reynolds, WF., Yu, M. Bonducellpins A-D, new cassane furanoditerpenes of Caesalpinia bonduc. JOURNAL OF NATURAL PRODUCTS, 1997, vol. 60, no. 12, p. 1219-1221. DOI
- Sivasankari, K., Janaky, S., Sekar, T. Evaluation of phytochemicals in select medicinal plants of the Caesalpinia species. Indian journal of science and technology, 2010, vol. 3, no. 12, p. 1118-1121. DOI
- Sukhdev, K.A., Dhondiram, M.Y., Khalure Pallavi, R., Balasaheb, C.N. Antifertility activity of root bark of Caesalpinia bonduc Linn. Roxb.in female albino rats. Pharmacologyonline, 2011, vol. 3, p. 34-41.
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.